Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
RESEARCH TOOLSreports
Elite Pharmaceuticals (ELTP) Stock Price & Analysis
124 Followers
ELTP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.03 - $0.21
Previous Close$0.2
Volume3.52M
Average Volume (3M)590.14K
Market Cap
$203.45M
Enterprise Value$205.53M
Total Cash (Recent Filing)$5.82M
Total Debt (Recent Filing)$7.89M
Price to Earnings (P/E)13.4
Beta-0.09
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding1,017,781,199
10 Day Avg. Volume321,140
30 Day Avg. Volume590,144
Standard Deviation0.21
R-Squared0.00045
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)4.19
Price to Sales (P/S)19.42
Price to Cash Flow (P/CF)-17.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.34
Enterprise Value/Gross Profit12.39
Enterprise Value/Ebitda610.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Elite Pharmaceuticals News
PremiumCompany Announcements
Elite Pharmaceuticals: Navigating Stock Market Fluctuations for Profit
PremiumCompany Announcements
Elite Pharmaceuticals Positions for Growth with Bold Acquisition
Ownership Overview
32.86% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
67.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ELTP FAQ
What was Elite Pharmaceuticals’s price range in the past 12 months?
Elite Pharmaceuticals lowest stock price was $0.03 and its highest was $0.21 in the past 12 months.
What is Elite Pharmaceuticals’s market cap?
Currently, no data Available
When is Elite Pharmaceuticals’s upcoming earnings report date?
Elite Pharmaceuticals’s upcoming earnings report date is Aug 12, 2024 which is in 41 days.
How were Elite Pharmaceuticals’s earnings last quarter?
Elite Pharmaceuticals released its earnings results on Jul 01, 2024. The company reported $0.003 earnings per share for the quarter, beating the consensus estimate of N/A by $0.003.
Is Elite Pharmaceuticals overvalued?
According to Wall Street analysts Elite Pharmaceuticals’s price is currently Overvalued.
Does Elite Pharmaceuticals pay dividends?
Elite Pharmaceuticals does not currently pay dividends.
What is Elite Pharmaceuticals’s EPS estimate?
Elite Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Elite Pharmaceuticals have?
Elite Pharmaceuticals has 1,017,781,200 shares outstanding.
What happened to Elite Pharmaceuticals’s price movement after its last earnings report?
Elite Pharmaceuticals reported an EPS of $0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Elite Pharmaceuticals?
Among the largest hedge funds holding Elite Pharmaceuticals’s share is Fisher Asset Management LLC. It holds Elite Pharmaceuticals’s shares valued at N/A.
---
Elite Pharmaceuticals Stock Smart Score
Company Description
Elite Pharmaceuticals
Elite Pharmaceuticals, Inc. engages in the development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) segments. The ANDA segment includes generic pharmaceuticals. The NDA segment comprises the branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
---
ELTP Earnings Call
Q3 2024
0:00 / 0:00
---
Technical Analysis
---